Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advisory bodies and committees (351)
- Scheduling (national classification system) (148)
- Prescription medicines (31)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicines safety (19)
- Therapeutic goods regulation (18)
- Medical devices safety (12)
- Manufacturing (11)
- Complementary medicines (9)
- Safety (9)
- Non-prescription medicines (8)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Registered complementary medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Import and export (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Sunscreens (1)
Results for
"[search-keyword]"
Search
688 result(s) found, displaying 501 to 525
-
Scheduling submissionsPublic submissions on matters referred to the July 2017 scheduling meetings, and received during the pre-meeting and interim decision consultation periods, are now available
-
Scheduling submissionsPublic submissions on interim scheduling decisions for substances referred to the November 2017 ACMS/ACCS meetings are now available
-
Scheduling decisions (final)Final decisions for substances referred to the ACMS, ACCS/ACMS, ACCS November 2017 meetings, and delegate only decisions on agricultural and veterinary chemicals and NCEs.
-
PublicationsReport detailing prescription medicines registrations for 2017
-
PublicationsNew generic medicines and biosimilar medicines registered in 2017
-
PublicationsA step-by-step guide for prescription medicines
-
Meeting statementsACM 6 meeting statement has been published
-
Meeting statementsACM 7 meeting statement has been published
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Scheduling submissionsPublic submissions on matters referred to the March 2017 scheduling meetings, and received during the pre-meeting and interim decision consultation periods, are now available
-
Meeting statementsACM 2 meeting statement has been published
-
Meeting statementsACM 3 meeting statement has been published
-
Meeting statementsACM 4 meeting statement has been published
-
Meeting statementsACM 5 meeting statement has been published
-
Meeting statementsAdvisory Committee on Medical Devices
-
Scheduling delegates' interim decisions and invitation for further comment: ACCS/ACMS, November 2017
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 5 March 2018 -
Scheduling decisions (final)Scheduling delegates' final decisions: NCEs, January 2017 now published
-
Meeting statementsACV 1 meeting statement has been published
-
Meeting statementsACV 2 meeting statement has been published
-
PublicationsThis document reflects the evidence supporting the use of medicinal cannabis in treating chronic pain and the recommendations of the Chronic Pain Working Group
-
Meeting statementsACMD 32 meeting statement has been published
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices